The Food and Drug Administration has revised its recommendations for testing blood donations for the Zika virus.
The Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) have updated guidelines for diagnosis and management of Clostridium difficile (C. diff).
A longitudinal study of Canadian boys with severe hemophilia showed that tailored frequency-escalated prophylaxis results in minimal long-term arthropathy and very good health outcomes, while reducing the quantity of costly clotting factor as compared with standard prophylaxis protocols.
Results from a clinical trial have led investigators to conclude adding longterm administration of human albumin to conventional treatment inpatients with decompensated cirrhosis appears to prolong survival.
HIV/AIDS researcher Robert Redfield, MD, has been named the next head of the Centers for Disease Control and Prevention.
The Health and Human Services Notice of Benefit and Payment Parameters for 2019 aims to increase state flexibility, improve affordability, strengthen program integrity, empower consumers, promote stability and reduce unnecessary regulatory burdens imposed by the Patient Protection and Affordable Care Act.
The finalized 2019 Medicare Advantage plan rates will rise an average of 3.4 percent, with other changes being implemented as well.
A pilot study conducted by U.S. investigators observed improvements in cognitive and behavioral function in 14 children with autism spectrum disorder and evidence of immune dysfunction who were administered high-dose intravenous immune globulin (IVIG) treatment over a period of 30 weeks.
New guidance from the Centers for Medicare and Medicaid Services allows work requirements to be used as a basis for eligibility for certain Medicaid beneficiaries.
The Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) have updated guidelines for diagnosis and management of Clostridium difficile (C. diff).
Grifols’ higher-potency rabies immune globulin (RIG), HyperRAB S/D, was made available to healthcare providers
FDA's Vaccines and Related Biological Products Advisory Committee chose the Northern Hemisphere’s 2018-19 influenza (flu) vaccine strains based on the World Health Organization’s recommendations.